Multimer Pharmacokinetics in Von Willebrand Disease
Investigation to compare the structure and function of the Recombinant von Willebrand factor with the human plasma-derived VWF. Read for more information
Stay updated with breaking news from Human Plasma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investigation to compare the structure and function of the Recombinant von Willebrand factor with the human plasma-derived VWF. Read for more information
When presented with ORLADEYO, both patients and physicians recognized immediately the freedom gained with the once-daily prophylactic therapy and indicated a high willingness to use.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Freeline to Present Data at the 2021 Virtual Congress of the European Association for ... Freeline TherapeuticsJanuary 26, 2021 GMT LONDON, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that it will presen...